Open AccessEvaluation of efficacy of twice-weekly prophylactic treatment with BeneFIX® (recombinant factor IX) followed by once weekly in children with severe hemophilia B: Six-year data from a local registry
Author(s) -
RafalRaad Al-Janabi,
AfrahA Salih,
M. J. Alwan
Publication year - 2021
Publication title -
iraqi journal of hematology
Language(s) - English
Resource type - Journals
eISSN - 2543-2702
pISSN - 2072-8069
DOI - 10.4103/ijh.ijh_51_20
Subject(s) - medicine , clinical endpoint , context (archaeology) , factor ix , clinical trial , surgery , pediatrics , paleontology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom